"New CDC Recommendation: Pfizer Vaccine Crucial for Protecting Newborns from RSV"

The Centers for Disease Control and Prevention (CDC) is urging pregnant women to get the newly approved RSV vaccine, Abrysvo, to protect their newborns from respiratory syncytial virus (RSV), which can be severe in infants. The vaccine reduces the risk of hospitalization for babies by 57% in the first six months after birth. Pregnant women are recommended to receive the vaccine between weeks 32 and 36 of their pregnancy. RSV is a common cause of illness in children, and severe cases can lead to hospitalization. The CDC also recommends the updated COVID-19 and influenza vaccines for anyone 6 months or older.